NeuroPace, Inc. (NPCE)
7.95
-0.19
(-2.33%)
USD |
NASDAQ |
Nov 20, 16:00
8.06
+0.11
(+1.38%)
After-Hours: 20:00
NeuroPace Total Assets (Quarterly) : 94.78M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.78M |
| June 30, 2026 | 96.99M |
| March 31, 2026 | 98.90M |
| December 31, 2025 | 193.94M |
| September 30, 2025 | 107.26M |
| June 30, 2025 | 106.11M |
| March 31, 2025 | 110.20M |
| December 31, 2024 | 94.65M |
| September 30, 2024 | 96.30M |
| June 30, 2024 | 94.39M |
| March 31, 2024 | 98.85M |
| December 31, 2023 | 107.65M |
| Date | Value |
|---|---|
| September 30, 2023 | 99.30M |
| June 30, 2023 | 102.23M |
| March 31, 2023 | 106.27M |
| December 31, 2022 | 114.11M |
| September 30, 2022 | 120.47M |
| June 30, 2022 | 118.54M |
| March 31, 2022 | 128.98M |
| December 31, 2021 | 133.56M |
| September 30, 2021 | 141.26M |
| June 30, 2021 | 146.97M |
| March 31, 2021 | 50.32M |
| December 31, 2020 | 55.95M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 1.159B |
| Axogen, Inc. | 550.34M |
| Accuray, Inc. | 390.06M |
| Orthofix Medical, Inc. | 855.76M |
| ResMed, Inc. | 8.212B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 83.28M |
| Shareholders Equity (Quarterly) | 11.49M |
| Debt to Equity Ratio | 6.051 |
| Current Ratio | 5.261 |
| Net Debt Paydown Yield | 0.08% |